FDA authorizes Novavax Covid-19 vaccine for emergency use in ages 12-17
In this age group, "overall, the clinical efficacy of the vaccine is around 80%," said Silvia Taylor, Novavax's senior vice president global corporate affairs. The vaccine has shown 90% overall efficacy in adults.Novavax announced in…